Processa Pharmaceuticals, Inc. Intangible Assets, Net (Excluding Goodwill)
Processa Pharmaceuticals, Inc. (PCSA) had Intangible Assets, Net (Excluding Goodwill) of $7.47 million as of 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2023-03-30
- 2022-09-30: Intangible Assets, Net (Excluding Goodwill) $7.47M.
- 2022-06-30: Intangible Assets, Net (Excluding Goodwill) $7.66M.
- 2022-03-31: Intangible Assets, Net (Excluding Goodwill) $7.86M.
- 2021-12-31: Intangible Assets, Net (Excluding Goodwill) $8.06M.
| Period end | Intangible Assets, Net (Excluding Goodwill) |
|---|---|
| 2022-09-30 | $7.47M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $7.66M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $7.86M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $8.06M 10-K · filed 2023-03-30 |
| 2021-09-30 | $8.25M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $8.45M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $8.65M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $8.85M 10-K · filed 2022-03-30 |
| 2020-09-30 | $9.05M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $9.24M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $9.44M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $9.64M 10-K · filed 2021-03-25 |
| 2019-09-30 | $9.84M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $10.04M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $10.24M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $10.44M 10-K · filed 2020-03-06 |
| 2018-09-30 | $10.64M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $10.82M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $11.01M 10-Q · filed 2018-05-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |